Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
DCBO Quote, Financials, Valuation and Earnings
Last price:
$29.97
Seasonality move
:
19.77%
Day range:
$28.72 - $29.62
52-week range:
$25.50 - $53.86
Dividend yield:
0%
P/E ratio:
39.95x
P/S ratio:
4.11x
P/B ratio:
16.71x
Volume:
36.4K
Avg. volume:
71.3K
1-year change:
-23.91%
Market cap:
$876M
Revenue:
$216.9M
EPS (TTM):
$0.74
Earnings Data
Next earnings date for DCBO
Aug 08
2025
Most recent earnings per share
$0.05
Missed by $0.17
(May 9/2025)
Consensus Estimate
$0.22
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DCBO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $60M | -- | -- | $0.29 | -- |
| 08/08/2025 | Q2 | $58.9M | -- | -- | $0.22 | -- |
| 05/09/2025 | Q1 | $57.1M | $57.3M | $0.05 | $0.22 | -$0.17 |
| 02/28/2025 | Q4 | $56.2M | $57M | $0.38 | $0.26 | $0.12 |
| 11/08/2024 | Q3 | $54.2M | $55.4M | $0.16 | $0.25 | -$0.09 |
| 08/08/2024 | Q2 | $52.3M | $53.1M | $0.15 | $0.22 | -$0.07 |
| 05/09/2024 | Q1 | $51.1M | $51.4M | $0.17 | $0.19 | -$0.02 |
| 02/23/2024 | Q4 | $48.4M | $49.3M | $0.10 | $0.14 | -$0.04 |
| 11/09/2023 | Q3 | $46M | $46.5M | $0.12 | $0.09 | $0.03 |
| 08/10/2023 | Q2 | $43.1M | $43.6M | -$0.17 | $0.07 | -$0.24 |
| 05/11/2023 | Q1 | $41.5M | $41.5M | $0.04 | $0.02 | $0.02 |
| 03/09/2023 | Q4 | -- | $39M | $0.05 | -- | -- |
| 11/10/2022 | Q3 | -- | $37M | $0.30 | -- | -- |
| 08/11/2022 | Q2 | -- | $34.9M | $0.06 | -- | -- |
| 05/12/2022 | Q1 | -- | $32.1M | -$0.21 | -- | -- |
| 03/10/2022 | Q4 | -- | $29.8M | -$0.04 | -- | -- |
| 11/11/2021 | Q3 | -- | $27.1M | $0.02 | -- | -- |
| 08/12/2021 | Q2 | -- | $25.6M | -$0.22 | -- | -- |
| 05/13/2021 | Q1 | -- | $21.7M | -$0.17 | -- | -- |
| 03/11/2021 | Q4 | -- | $18.8M | -$0.14 | -- | -- |
| 11/12/2020 | Q3 | -- | $16.1M | -$0.04 | -- | -- |
| 08/06/2020 | Q2 | -- | $14.5M | -$0.12 | -- | -- |
| 05/12/2020 | Q1 | -- | $13.5M | $0.03 | -- | -- |
| 03/12/2020 | Q4 | -- | $12.3M | -$0.12 | -- | -- |
| 09/30/2019 | Q3 | -- | $10.6M | -$0.13 | -- | -- |
| 06/30/2019 | Q2 | -- | $9.9M | -$0.08 | -- | -- |
| 03/31/2019 | Q1 | -- | $8.6M | -$0.09 | -- | -- |
| 12/31/2018 | Q4 | -- | $8M | -$0.11 | -- | -- |
| 09/30/2018 | Q3 | -- | $6.9M | -$0.07 | -- | -- |
| 06/30/2018 | Q2 | -- | $6.4M | -$0.12 | -- | -- |
Docebo Earnings Questions
-
How Much did Docebo Generate in Revenue Last Quarter?
Docebo reported $57.3M worth of top line sales in its most recent quarter.
-
Did Docebo Beat Earnings Last Quarter?
Docebo announced earnings per share of $0.05 which represents a miss of analyst forecast a $0.22 per share.
-
Is Docebo Profitable?
Docebo reported $45.9M that represents $1.48 per share over the last quarter.
-
What is the Analyst Consensus for Docebo EPS Next Year?
Docebo's earnings are forecast to grow from $0.86 per share to $0.96 per share next year representing an increase of 26.44%.
-
When is Docebo's Earnings Date?
Docebo's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
